{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T11:40:08Z","timestamp":1738755608554,"version":"3.37.0"},"reference-count":38,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0242","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T10:34:52Z","timestamp":1738751692000},"source":"Crossref","is-referenced-by-count":0,"title":["Online radiotherapy\u2014the paradigm shift to real-time adaptive radiotherapy"],"prefix":"10.3238","author":[{"given":"Goda","family":"Kalinauskaite","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Wittig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Z\u00f6phel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Senger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"10.3238\/arztebl.m2024.0242_ref1","doi-asserted-by":"crossref","unstructured":"Yan D, Vicini F, Wong J, Martinez A: Adaptive radiation therapy. Phys Med Biol 1997; 42: 123\u201332","DOI":"10.1088\/0031-9155\/42\/1\/008"},{"key":"10.3238\/arztebl.m2024.0242_ref2","doi-asserted-by":"crossref","unstructured":"Dona Lemus OM, Cao M, Cai B, Cummings M, Zheng D: Adaptive radiotherapy: next-generation radiotherapy. Cancers (Basel) 2024; 16: 1206","DOI":"10.3390\/cancers16061206"},{"key":"10.3238\/arztebl.m2024.0242_ref3","unstructured":"Archambault Y, Boylan C, Bullock D, et al.: Making on-line adaptive radiotherapie possible using artificial intelligence and machine learning for efficient daily re-planning. Medical Physics International 2020; 8: 77\u201386."},{"key":"10.3238\/arztebl.m2024.0242_ref4","doi-asserted-by":"crossref","unstructured":"Blumenfeld P, Arbit E, Den R, et al.: Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer. Radiat Oncol 2024; 19: 43","DOI":"10.1186\/s13014-024-02436-3"},{"key":"10.3238\/arztebl.m2024.0242_ref5","doi-asserted-by":"crossref","unstructured":"Pollard JM, Wen Z, Sadagopan R, Wang J, Ibbott GS: The future of image-guided radiotherapy will be MR guided. Br J Radiol 2017; 90 (1073): 20160667","DOI":"10.1259\/bjr.20160667"},{"key":"10.3238\/arztebl.m2024.0242_ref6","unstructured":"Universit\u00e4tsklinikum T\u00fcbingen www.medizin.uni-tuebingen.de\/de\/strahlentherapie-mr-linac (last accessed on 27 October 2024)."},{"key":"10.3238\/arztebl.m2024.0242_ref7","unstructured":"Universit\u00e4tsklinikum Heidelberg: www.klinikum.uni-heidelberg.de\/radiologische-klinik\/radioonkologie-und-strahlentherapie\/behandlungsspektrum\/therapieangebote\/mr-gefuehrte-strahlentherapie-mit-dem-mr-linac (last accessed on 27 October 2024)."},{"key":"10.3238\/arztebl.m2024.0242_ref8","unstructured":"LMU-Klinikum: www.lmu-klinikum.de\/strahlentherapie-und-radioonkologie (last accessed on 27 October 2024)."},{"key":"10.3238\/arztebl.m2024.0242_ref9","unstructured":"Universit\u00e4tsklinikum Carl Gustav Carus: www.nct-dresden.de\/de\/fuer-patienten\/behandlung\/strahlentherapie (last accessed on 27 October 2024)."},{"key":"10.3238\/arztebl.m2024.0242_ref10","doi-asserted-by":"crossref","unstructured":"Sher DJ, Avkshtol V, Lin MH, et al.: Acute toxicity and efficiency outcomes in the DARTBOARD randomized trial of daily adaptive radiotherapy for head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2023; 117: e6","DOI":"10.1016\/j.ijrobp.2023.08.032"},{"key":"10.3238\/arztebl.m2024.0242_ref11","doi-asserted-by":"crossref","unstructured":"Boeke S, Uder L, Ehlers J, et al.: Online MR guided dose escalated radiotherapy for organ preservation in distal rectal cancer. Clin Transl Radiat Oncol 2022; 37: 153\u20136","DOI":"10.1016\/j.ctro.2022.10.003"},{"key":"10.3238\/arztebl.m2024.0242_ref12","doi-asserted-by":"crossref","unstructured":"Bruynzeel AME, Tetar SU, Oei SS, et al.: A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate cancer: early toxicity results. Int J Radiat Oncol Biol Phys 2019; 105: 1086\u201394","DOI":"10.1016\/j.ijrobp.2019.08.007"},{"key":"10.3238\/arztebl.m2024.0242_ref13","doi-asserted-by":"crossref","unstructured":"Fink CA, Ristau J, Buchele C, et al.: Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer\u2014acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial. Clin Transl Radiat Oncol 2024; 46: 100771","DOI":"10.1016\/j.ctro.2024.100771"},{"key":"10.3238\/arztebl.m2024.0242_ref14","doi-asserted-by":"crossref","unstructured":"Castelli J, Thariat J, Benezery K, et al.: Weekly adaptive radiotherapy vs standard intensity-modulated radiotherapy for improving salivary function in patients with head and neck cancer: a phase 3 randomized clinical trial. JAMA Oncol 2023; 9: 1056\u201364","DOI":"10.1001\/jamaoncol.2023.1352"},{"key":"10.3238\/arztebl.m2024.0242_ref15","doi-asserted-by":"crossref","unstructured":"de Leeuw ALMP, Giralt J, Tao Y, et al.: A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE). Radiother Oncol 2024; 196: 110281","DOI":"10.1016\/j.radonc.2024.110281"},{"key":"10.3238\/arztebl.m2024.0242_ref16","doi-asserted-by":"crossref","unstructured":"De Bruycker A, De Neve W, Daisne JF, et al.: Disease control and late toxicity in adaptive dose painting by numbers versus nonadaptive radiation therapy for head and neck cancer: a randomized controlled phase 2 trial. Int J Radiat Oncol Biol Phys 2024; 120: 516\u201327","DOI":"10.1016\/j.ijrobp.2024.01.012"},{"key":"10.3238\/arztebl.m2024.0242_ref17","doi-asserted-by":"crossref","unstructured":"Zhu Y, Sun X, Jiang C, et al.: Adaptive radiotherapy guided by PET\/CT in patients with locally advanced non\u2013small cell lung cancer: a phase II randomized study. Int J Radiat Oncol Biol Phys 2023; Volume 117, Issue 2, Supplement: S28","DOI":"10.1016\/j.ijrobp.2023.06.288"},{"key":"10.3238\/arztebl.m2024.0242_ref18","doi-asserted-by":"crossref","unstructured":"Ghosh Laskar S, Sinha S, Kumar A, et al.: Reducing salivary toxicity with adaptive radiotherapy (ReSTART): a randomized controlled trial comparing conventional IMRT to adaptive IMRT in head and neck squamous cell carcinomas. Clin Oncol (R Coll Radiol) 2024; 36: 353\u201361","DOI":"10.1016\/j.clon.2024.03.015"},{"key":"10.3238\/arztebl.m2024.0242_ref19","doi-asserted-by":"crossref","unstructured":"Nutting C, Finneran L, Roe J, et al.: Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial. Lancet Oncol 2023; 24: 868\u201380","DOI":"10.1016\/S1470-2045(23)00265-6"},{"key":"10.3238\/arztebl.m2024.0242_ref20","doi-asserted-by":"crossref","unstructured":"Bradley JD, Hu C, Komaki RR, et al.: Long-term results of NRG oncology RTOG 0617: standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer. J Clin Oncol 2020; 38: 706\u201314","DOI":"10.1200\/JCO.19.01162"},{"key":"10.3238\/arztebl.m2024.0242_ref21","doi-asserted-by":"crossref","unstructured":"Antonia SJ, Villegas A, Daniel D, et al.: Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med 2017; 377: 1919\u201329","DOI":"10.1056\/NEJMoa1709937"},{"key":"10.3238\/arztebl.m2024.0242_ref22","doi-asserted-by":"crossref","unstructured":"M\u00f8ller DS, Lutz CM, Khalil AA, et al.: Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy. Radiother Oncol 2022; 168: 234\u201340","DOI":"10.1016\/j.radonc.2022.01.039"},{"key":"10.3238\/arztebl.m2024.0242_ref23","doi-asserted-by":"crossref","unstructured":"Chuong MD, Lee P, Low DA, et al.: Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study. Radiother Oncol 2024; 191: 110064","DOI":"10.1016\/j.radonc.2023.110064"},{"key":"10.3238\/arztebl.m2024.0242_ref24","doi-asserted-by":"crossref","unstructured":"Boekhoff MR, Bouwmans R, Doornaert PAH, et al.: Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: an R-IDEAL stage 1b\/2a evaluation of technical innovation. Clin Transl Radiat Oncol 2022; 34: 82\u20139","DOI":"10.1016\/j.ctro.2022.03.008"},{"key":"10.3238\/arztebl.m2024.0242_ref25","doi-asserted-by":"crossref","unstructured":"Westerhoff JM, Daamen LA, Christodouleas JP, et al.: Safety and tolerability of online adaptive high-field magnetic resonance-guided radiotherapy. JAMA Netw Open 2024; 7: e2410819","DOI":"10.1001\/jamanetworkopen.2024.10819"},{"key":"10.3238\/arztebl.m2024.0242_ref26","doi-asserted-by":"crossref","unstructured":"Feng L, Tyagi N, Otazo R: MRSIGMA: Magnetic resonance SIGnature MAtching for real-time volumetric imaging. Magn Reson Med 2020; 84: 1280\u201392","DOI":"10.1002\/mrm.28200"},{"key":"10.3238\/arztebl.m2024.0242_ref27","doi-asserted-by":"crossref","unstructured":"Finazzi T, Haasbeek CJA, Spoelstra FOB, et al.: Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors. Int J Radiat Oncol Biol Phys 2020; 107: 270\u20138","DOI":"10.1016\/j.ijrobp.2020.02.025"},{"key":"10.3238\/arztebl.m2024.0242_ref28","doi-asserted-by":"crossref","unstructured":"Ehrbar S, Braga K\u00e4ser S, Chamberlain M, et al.: MR-guided beam gating: residual motion, gating efficiency and dose reconstruction for stereotactic treatments of the liver and lung. Radiother Oncol 2022: 174: 101\u20138","DOI":"10.1016\/j.radonc.2022.07.007"},{"key":"10.3238\/arztebl.m2024.0242_ref29","doi-asserted-by":"crossref","unstructured":"Otazo R, Lambin P, Pignol JP, et al.: MRI-guided radiation therapy: an emerging paradigm in adaptive radiation oncology. Radiology 2021; 298: 248\u201360","DOI":"10.1148\/radiol.2020202747"},{"key":"10.3238\/arztebl.m2024.0242_ref30","doi-asserted-by":"crossref","unstructured":"Almansour H, Schick F, Nachbar M, et al.: Longitudinal monitoring of apparent diffusion coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study. Radiol Oncol 2023; 57: 184\u201390","DOI":"10.2478\/raon-2023-0020"},{"key":"10.3238\/arztebl.m2024.0242_ref31","doi-asserted-by":"crossref","unstructured":"Haertter A, Salerno M, Koger B, et al.: ACR benchmark testing of a novel high-speed ring-gantry linac kV-CBCT system. J Appl Clin Med Phys 2024; 25: e14299","DOI":"10.1002\/acm2.14299"},{"key":"10.3238\/arztebl.m2024.0242_ref32","doi-asserted-by":"crossref","unstructured":"Kunnen B, van de Schoot AJAJ, Fremeijer KP, et al.: The added value of a new high-performance ring-gantry CBCT imaging system for prostate cancer patients. Radiother Oncol 2024; 200: 110458","DOI":"10.1016\/j.radonc.2024.110458"},{"key":"10.3238\/arztebl.m2024.0242_ref33","doi-asserted-by":"crossref","unstructured":"Nelissen KJ, Versteijne E, Senan S, et al.: Same-day adaptive palliative radiotherapy without prior CT simulation: early outcomes in the FAST-METS study. Radiother Oncol 2023; 182: 109538","DOI":"10.1016\/j.radonc.2023.109538"},{"key":"10.3238\/arztebl.m2024.0242_ref34","doi-asserted-by":"crossref","unstructured":"Steenbakkers RJHM, Duppen JC, Fitton I, et al.: Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys 2006; 64: 435\u201348","DOI":"10.1016\/j.ijrobp.2005.06.034"},{"key":"10.3238\/arztebl.m2024.0242_ref35","doi-asserted-by":"crossref","unstructured":"L\u00f6ck S, Perrin R, Seidlitz A, et al.: Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging. Radiother Oncol 2017; 124: 533\u201340","DOI":"10.1016\/j.radonc.2017.08.010"},{"key":"10.3238\/arztebl.m2024.0242_ref36","doi-asserted-by":"crossref","unstructured":"Riaz N, Sherman E, Pei X, et al.: Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial. J Natl Cancer Inst 2021; 113: 742\u201351","DOI":"10.1093\/jnci\/djaa184"},{"key":"10.3238\/arztebl.m2024.0242_ref37","doi-asserted-by":"crossref","unstructured":"Finazzi T, Palacios MA, Spoelstra FOB, et al.: Role of on-table plan adaptation in MR-guided ablative radiation therapy for central lung tumors. Int J Radiat Oncol Biol Phys 2019; 104: 933\u201341","DOI":"10.1016\/j.ijrobp.2019.03.035"},{"key":"10.3238\/arztebl.m2024.0242_ref38","doi-asserted-by":"crossref","unstructured":"Verkooijen HM, Kerkmeijer LGW, Fuller CD, et al.: R-IDEAL: a framework for systematic clinical evaluation of technical innovations in radiation oncology. Front Oncol 2017; 7: 59","DOI":"10.3389\/fonc.2017.00059"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T10:35:22Z","timestamp":1738751722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0242","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}